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===================

*Stenotrophomonas maltophilia* was first isolated in 1943 as *Bacterium bookeri* and was then named *Pseudomonas maltophilia* ([@B1]). Later, however, investigators using rRNA cistron analysis determined that this microorganism was more appropriately named *Xanthomonas maltophilia*. More recently, DNA-rRNA hybridization studies and sequencing and mapping of PCR-amplified 16S rRNA genes have resulted in the classification and naming of *X. maltophilia* as *Stenotrophomonas maltophilia* ([@B2]). *S. maltophilia* is predominantly found in an aquatic or humid environment, and in hospitals, *S. maltophilia* is found as a contaminant of numerous medical devices, edetic acid anticoagulant in vacuum tubes for blood collection, chlorhexidine-cetrimide disinfectant, and sterile water ([@B3]).

*S. maltophilia* is the third most common nosocomial nonfermenting Gram-negative bacillus ([@B4]). A recent study shows that 4.3% of almost 75,000 Gram-negative infections were caused by *S. maltophilia* in intensive care units in the United States ([@B5]). The two most common diseases caused by *S. maltophilia* are bacteremia and pneumonia, with infection being via an intravascular catheter or ventilator, respectively ([@B5]). In addition, *S. maltophilia* is intrinsically resistant to a variety of clinically prescribed antibiotics ([@B3]). Also, *S. maltophilia* can form biofilms, which further increases its resistance to phagocytes and antibiotics ([@B3]).

*S*. *maltophilia* strain AU12-09 was isolated from an intravascular catheter tip by rolling the tip back and forth on the surface of a Columbia agar plate supplemented with 5% sheep blood, essentially as described by Maki et al. ([@B6]). DNA was prepared and the genome sequence of *S. maltophilia* AU12-09 was determined on a 454 GS FLX system using titanium chemistry (Roche) ([@B7]). The sequence data consist of 129,784,052 bp of DNA sequence at 29× coverage. A total of 125 contigs (\>500 bp) were *de novo* assembled using the Roche GS *de novo* assembler (version 2.3). The contig N~50~ was 69,081 bp, and the largest contig assembled was 320,581 bp. The contigs were then ordered and oriented into four scaffolds using paired-end information. The average length of the scaffolds was 1,145,290 bp.

The draft genome of *S. maltophilia* AU12-09 consists of a circular 4,547,300-bp chromosome with a G+C content of 66.5%. The genome was automatically annotated using the RAST server ([@B8]). The genome contains 70 tRNA genes coding for all amino acids and 4,004 predicted protein-coding genes, consistent with other sequenced *Stenotrophomonas* spp. ([@B5], [@B9]). We identified numerous putative virulence factors, including those involved in quorum sensing, biofilm formation, and the production of bacteriocins and invasins. The *S. maltophilia* AU12-09 genome contains 24 genes coding for multidrug resistance efflux pumps, 11 genes coding for resistance to beta-lactam antibiotics, 5 genes coding for multidrug resistance tripartite systems, and 4 genes coding for resistance to fluoroquinolones.

This sequence information for the *S. maltophilia* genome will greatly improve our understanding of the drug resistance and pathogenicity of this organism.

Nucleotide sequence accession number. {#h1}
-------------------------------------

The genome sequence of *S. maltophilia* AU12-09 has been deposited in NCBI GenBank under accession no [APIT00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=APIT00000000).
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